T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)

NCT01853748 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

512

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Trastuzumab
DRUG: Paclitaxel
DRUG: Trastuzumab emtansine

Sponsor

Dana-Farber Cancer Institute